(Q84366967)
Statements
A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors (English)
Roy S Herbst
David S Hong
Daniel W Bowles
Gerald S Falchook
Wells A Messersmith
Goldy C George
Cindy L O'Bryant
Alex C H Vo
Kevin Klucher
S Gail Eckhardt
Scott Peterson
Diana F Hausman
Antonio Jimeno